Early research (Phase 1)Study completedNCT01690377What this trial is testingNatural Dendritic Cell Vaccines in Metastatic Melanoma PatientsWho this might be right forMelanoma Radboud University Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT05370807What this trial is testingA Clinical Trial of Regorafenib in Patients With Pretreated Advanced MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IV Universitair Ziekenhuis Brussel 48
Early research (Phase 1)Ended earlyNCT01216436What this trial is testingLocal Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic MelanomaWho this might be right forMetastatic Melanoma Duke University 2
Testing effectiveness (Phase 2)Ended earlyNCT01350401What this trial is testingPhase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic MelanomaWho this might be right forMelanoma Adaptimmune 4
Testing effectiveness (Phase 2)WithdrawnNCT01764009What this trial is testingSafety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic MelanomaWho this might be right forMelanoma Valerio Therapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT05655312What this trial is testingMC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced MelanomaWho this might be right forRecurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more Perspective Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT03635983What this trial is testingNKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 783
Not applicableStudy completedNCT06549439What this trial is testingEFLASH for Skin Lesions of Malignant MelanomasWho this might be right forMetastatic Melanoma University of Zurich 7
Early research (Phase 1)Study completedNCT01065467What this trial is testingPanobinostat (LBH589) in Patients With Metastatic MelanomaWho this might be right forMelanomaMalignant Melanoma Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT02821182What this trial is testingA Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.Who this might be right forMelanoma University Hospital, Ghent 20
Testing effectiveness (Phase 2)Study completedNCT00509288What this trial is testingPhase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered LymphocytesWho this might be right forMelanomaSkin Cancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT04007588What this trial is testingA Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV MelanomaWho this might be right forMelanoma Stage IIIMelanoma Stage IV Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00738361What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By SurgeryWho this might be right forIntraocular Melanoma Ohio State University Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00096382What this trial is testingCyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Institutes of Health Clinical Center (CC) 34
Not applicableStudy completedNCT05954546What this trial is testingCompare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial SettingsWho this might be right forMetastatic Melanoma Pfizer 275
Large-scale testing (Phase 3)WithdrawnNCT01861938What this trial is testingModified Melanoma Vaccine for High Risk or Low Residual Disease PatientsWho this might be right forHigh Risk HLA-A2+ MelanomaMetastatic Disease Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT00755976What this trial is testingSulindac and Epirubicin in Treating Patients With Metastatic Malignant MelanomaWho this might be right forMelanoma (Skin) Cancer Trials Ireland 32
Testing effectiveness (Phase 2)Study completedNCT02272855What this trial is testingCombination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic MelanomaWho this might be right forMalignant Melanoma Takara Bio Inc. 46
Large-scale testing (Phase 3)Study completedNCT01597908What this trial is testingDabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous MelanomaWho this might be right forMelanoma Novartis Pharmaceuticals 704
Testing effectiveness (Phase 2)Ended earlyNCT00003552What this trial is testingChemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic MelanomaWho this might be right forStage IV MelanomaRecurrent Melanoma National Heart, Lung, and Blood Institute (NHLBI)